BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15611106)

  • 21. Oligomerization of wild type and nonfunctional mutant angiotensin II type I receptors inhibits galphaq protein signaling but not ERK activation.
    Hansen JL; Theilade J; Haunsø S; Sheikh SP
    J Biol Chem; 2004 Jun; 279(23):24108-15. PubMed ID: 15056658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*.
    Oakley RH; Laporte SA; Holt JA; Barak LS; Caron MG
    J Biol Chem; 2001 Jun; 276(22):19452-60. PubMed ID: 11279203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protease-activated receptor-2 simultaneously directs beta-arrestin-1-dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase.
    Wang P; DeFea KA
    Biochemistry; 2006 Aug; 45(31):9374-85. PubMed ID: 16878972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
    Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.
    McDonald PH; Chow CW; Miller WE; Laporte SA; Field ME; Lin FT; Davis RJ; Lefkowitz RJ
    Science; 2000 Nov; 290(5496):1574-7. PubMed ID: 11090355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
    Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
    J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling.
    Kim J; Ahn S; Ren XR; Whalen EJ; Reiter E; Wei H; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1442-7. PubMed ID: 15671181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances beta-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation.
    Charest PG; Bouvier M
    J Biol Chem; 2003 Oct; 278(42):41541-51. PubMed ID: 12900404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.
    DeFea KA; Zalevsky J; Thoma MS; Déry O; Mullins RD; Bunnett NW
    J Cell Biol; 2000 Mar; 148(6):1267-81. PubMed ID: 10725339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential conformational requirements for activation of G proteins and the regulatory proteins arrestin and G protein-coupled receptor kinase in the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein.
    Vilardaga JP; Frank M; Krasel C; Dees C; Nissenson RA; Lohse MJ
    J Biol Chem; 2001 Sep; 276(36):33435-43. PubMed ID: 11387315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.
    Huet E; Boulay F; Barral S; Rabiet MJ
    Cell Signal; 2007 Sep; 19(9):1939-48. PubMed ID: 17594911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
    Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
    Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
    Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
    Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
    J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysophosphatidylcholines activate G2A inducing G(αi)₋₁-/G(αq/)₁₁- Ca²(+) flux, G(βγ)-Hck activation and clathrin/β-arrestin-1/GRK6 recruitment in PMNs.
    Khan SY; McLaughlin NJ; Kelher MR; Eckels P; Gamboni-Robertson F; Banerjee A; Silliman CC
    Biochem J; 2010 Nov; 432(1):35-45. PubMed ID: 20799926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation.
    McLaughlin NJ; Banerjee A; Kelher MR; Gamboni-Robertson F; Hamiel C; Sheppard FR; Moore EE; Silliman CC
    J Immunol; 2006 Jun; 176(11):7039-50. PubMed ID: 16709866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Gα(q/11) and β-arrestin-dependent manner.
    Szereszewski JM; Pampillo M; Ahow MR; Offermanns S; Bhattacharya M; Babwah AV
    PLoS One; 2010 Sep; 5(9):e12964. PubMed ID: 20886089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.
    Gesty-Palmer D; El Shewy H; Kohout TA; Luttrell LM
    J Biol Chem; 2005 Sep; 280(37):32157-67. PubMed ID: 16027114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference.
    Ahn S; Nelson CD; Garrison TR; Miller WE; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1740-4. PubMed ID: 12582207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the GRK2 binding site of Galphaq.
    Day PW; Tesmer JJ; Sterne-Marr R; Freeman LC; Benovic JL; Wedegaertner PB
    J Biol Chem; 2004 Dec; 279(51):53643-52. PubMed ID: 15471870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.